logo
#

Latest news with #BiJingquan

China investigating former head of food and drug watchdog
China investigating former head of food and drug watchdog

Reuters

time29-05-2025

  • Business
  • Reuters

China investigating former head of food and drug watchdog

BEIJING, May 29 (Reuters) - Bi Jingquan, former head of the now-defunct China Food and Drug Administration (CFDA), is being investigated for suspected corruption, China's anti-graft watchdog said on Thursday. Bi, a member of the standing committee of China's top political advisory body and a deputy director of its committee for economic affairs, is being investigated for suspected serious violations of law and discipline, the watchdog said, without giving details. Reuters was not able to reach Bi for comment. Bi, 69, holds a degree in economics from the prestigious Peking University and has served in senior positions in the National Development and Reform Commission, China's state planner, and State Council, China's cabinet. He was appointed chief of the CFDA in early 2015, a few months before the government launched a major revamp of China's drug review procedure. During his tenure at CFDA, Bi spearheaded efforts to simplify and expedite the review process for new drugs, and introduced steps to improve the quality of generic drugs. In 2018, Bi resigned from the CFDA amid fallout from a major vaccine scandal.

China Probes Former Food and Drug Authority Chief for Violation
China Probes Former Food and Drug Authority Chief for Violation

Bloomberg

time29-05-2025

  • Health
  • Bloomberg

China Probes Former Food and Drug Authority Chief for Violation

Beijing is investigating Bi Jingquan, a deputy chief of the economic affairs committee under China's top political advisory body, for alleged law violations, according to a Thursday statement from the Central Commission for Discipline Inspection. The anti-corruption watchdog gave no details about the suspected violations. Bi, 69, served as the chief of the China Food and Drug Administration from 2015 to 2018, when he introduced regulatory overhauls that spurred innovation in China's pharmaceutical sector.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store